Kurt J. Hilzinger - 31 Mar 2022 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Kurt J. Hilzinger
Issuer symbol
HUM
Transactions as of
31 Mar 2022
Net transactions value
+$91,971
Form type
4
Filing time
04 Apr 2022, 11:34:08 UTC
Previous filing
24 Mar 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 19,448 31 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $91,971 +209 +1.9% $440.06 11,465 31 Mar 2022 Humana Common 209 Direct F3
holding HUM Restricted Stock Units 22,029 31 Mar 2022 Humana Common 22,029 Direct F1
holding HUM Restricted Stock Units 1,679 31 Mar 2022 Humana Common 1,679 Direct F2
holding HUM Restricted Stock Units 412 31 Mar 2022 Humana Common 412 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022.